Red Flags Detected
- Material Weakness (worsened) — Material weaknesses now specifically identified as IT/QuickBooks controls and Purchase-to-Pay controls, providing more detail on scope than prior year's generic disclosure.
- Goodwill Impairment (new) — Company recorded $8.4M goodwill impairment in Q1 2026 due to sustained market-cap decline.
- Asset Impairment (new) — Company recorded $3.7M IPR&D asset impairment in Q1 2026 reflecting heightened uncertainty in advancing AKTX-101 under current capital constraints.
AKTX posts $12M impairment on Peak Bio assets; control weaknesses persist into 2026
Filed May 19, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 14, 2025 · ~1 min read
5 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade AKTX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
View original filing on SEC.gov
Generated by AI · May 26, 2026 7:37 AM